ECO 2013: seca mBCA –

the future of obesity treatment.

- ECO 2013, the 20th European Congress on Obesity, will be held in Liverpool, Great Britain, from 12 to 15 May 2013. At the annual meeting of the EASO, the European Association for the Study of Obesity, researchers and clinicians discuss the latest research results and methodological innovations in the obesity field. Body composition analysis is one of the topics receiving close attention.

seca mBCA – developed for medical use
The medical Body Composition Analyzer seca mBCA is state-of-the-art body composition analysis. International studies (current status: seca studies) validated the seca mBCA against the gold standard and documented the medical precision of the device’s measurements. In the treatment of obesity, the doctor uses the seca mBCA to measure the patient’s fat mass. Then he calculates energy stores and determines the patient’s energy consumption per day to devise a weight loss diet. The seca mBCA shows whether the goal of fat reduction and muscle mass increase has been achieved. The patient is motivated when he knows that even though his weight is not changing, his body composition is developing positively.

seca is presenting the seca mBCA at Stand 20/21 in the exhibition held in conjunction with the ECO 2013. All congress attendees are invited to have their body composition analyzed in a measurement that takes less than 20 seconds. During a visit to the seca stand doctors can gather the latest information about bioelectrical impedance analysis. 

More information about seca mBCA at:


Пресс-служба seca.

Вы представитель прессы и хотели бы получить информацию о нашем предприятии или наших продуктах? С помощью E-Mail-формуляра Вы можете непосредственно связаться с нашей пресс-службой.

Поля, отмеченные звёздочкой (*) являются обязательными для заполнения. Все другие данные являются необязательными.

News Form ru

Individual Subject (grey)
standard fields (grey)
Submit field